TransMedics Group, Inc. (TMDX) Dividend History

Company News

• TransMedics Group Stock Is Up 81% in 2025. Can It Climb Even Higher?

  TransMedics Group, a medical device company, saw its stock soar after a strong Q1 earnings report. However, the company faces competition from OrganOx, which could impact its liver transplant business. The article analyzes the company's growth potential and valuation to determine if it's a good investment.

  The Motley Fool
• Investor Alert: Wolfspeed, Driven Brands Holdings, Hasbro, and TransMedics: Johnson Fistel, PLLP Investigates Claims on Behalf of Investors

  Johnson Fistel, PLLP is investigating potential violations of federal and state laws by certain officers of Wolfspeed, Driven Brands Holdings, Hasbro, and TransMedics Group. The investigations are related to alleged misrepresentations and omissions made by the companies.

  GlobeNewswire Inc.

  Featured Companies: DRVN HAS WOLF
• 1 Beaten-Down Stock to Buy Right Now and Hold for a Decade

  TransMedics Group (TMDX) is a medical technology company that has developed a device called the Organ Care System (OCS) to help store donor organs. Despite recent headwinds, the company's superior technology and the expected growth in the number of organ donors could drive its results over the next decade.

  The Motley Fool
• המועד האחרון לתביעה נגד TMDX ביום שלישי: רוזן, יועץ גלובלי בכיר ביותר, מעודד את המשקיעים ב- TransMedics Group, Inc. עם הפסדים של יותר מ-100 אלף דולר להבטיח ייעוץ לפני המועד האחרון החשוב של 15 באפריל בתביעה ייצוגית בניירות ערך שהוגשה לראשונה על ידי המשרד - TMDX

  The article discusses a securities class action lawsuit against TransMedics Group, Inc. (TMDX) and encourages investors who purchased TMDX securities during the class period to seek legal counsel before the important April 15 deadline.

  GlobeNewswire Inc.
• Scott+Scott Attorneys at Law LLP Continues to Remind Investors of The Ongoing Securities Class Action Against TransMedics Group, Inc. (NASDAQ: TMDX)

  Scott+Scott Attorneys at Law LLP has filed a securities class action lawsuit against TransMedics Group, Inc. (NASDAQ: TMDX) alleging the company made misleading statements and omissions regarding its business practices, which included illegal, anticompetitive, and coercive tactics such as kickbacks, billing fraud, and overcharging patients.

  GlobeNewswire Inc.